Amelioration of Experimental Autoimmune Encephalomyelitis by Anatabine
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Amelioration of Experimental Autoimmune Encephalomyelitis by Anatabine
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 1, Pages e55392
Publisher
Public Library of Science (PLoS)
Online
2013-01-31
DOI
10.1371/journal.pone.0055392
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nicotinic Attenuation of Central Nervous System Inflammation and Autoimmunity
- (2014) F.-D. Shi et al. JOURNAL OF IMMUNOLOGY
- Neurodegeneration and Neuroprotection in Multiple Sclerosis
- (2012) Martin Stangel CURRENT PHARMACEUTICAL DESIGN
- Anatabine Ameliorates Experimental Autoimmune Thyroiditis
- (2012) Patrizio Caturegli et al. ENDOCRINOLOGY
- Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation
- (2012) Daniel Paris et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Neurodegeneration in multiple sclerosis: novel treatment strategies
- (2012) Felix Luessi et al. Expert Review of Neurotherapeutics
- Induction and molecular signature of pathogenic TH17 cells
- (2012) Youjin Lee et al. NATURE IMMUNOLOGY
- Inflammation-Mediated Memory Dysfunction and Effects of a Ketogenic Diet in a Murine Model of Multiple Sclerosis
- (2012) Do Young Kim et al. PLoS One
- Soluble IL-2Rα (sCD25) Exacerbates Autoimmunity and Enhances the Development of Th17 Responses in Mice
- (2012) Shane E. Russell et al. PLoS One
- Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation
- (2012) H. Qin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
- (2011) Cris S Constantinescu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Anatabine lowers Alzheimer's Aβ production in vitro and in vivo
- (2011) Daniel Paris et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Distinct pathological patterns in relapsing–remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate
- (2011) Rina Aharoni et al. JOURNAL OF AUTOIMMUNITY
- Tristetraprolin Mediates Anti-inflammatory Effects of Nicotine in Lipopolysaccharide-stimulated Macrophages
- (2011) Yeonsoo Joe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Th17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis
- (2011) F. Jadidi-Niaragh et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- 4 2 Nicotinic Receptors Partially Mediate Anti-Inflammatory Effects through Janus Kinase 2-Signal Transducer and Activator of Transcription 3 but Not Calcium or cAMP Signaling
- (2010) V. Hosur et al. MOLECULAR PHARMACOLOGY
- Activation of the Cholinergic Anti-Inflammatory System by Nicotine Attenuates Neuroinflammation via Suppression of Th1 and Th17 Responses
- (2009) E. Nizri et al. JOURNAL OF IMMUNOLOGY
- Severe relapses after the first infusion of natalizumab in active relapsing—remitting multiple sclerosis
- (2009) Francesca Rinaldi et al. Multiple Sclerosis Journal
- Mitoxantrone: benefits and risks in multiple sclerosis patients
- (2009) V. Martinelli et al. NEUROLOGICAL SCIENCES
- Inhibition of lipopolysaccharide-induced nitric oxide synthesis by nicotine through S6K1-p42/44 MAPK pathway and STAT3 (Ser 727) phosphorylation in Raw 264.7 cells
- (2008) Shin-Young Park et al. CYTOKINE
- Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis
- (2007) John S. Tzartos et al. AMERICAN JOURNAL OF PATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now